199 related articles for article (PubMed ID: 9835529)
21. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
Koyano S; Suzutani T; Yoshida I; Azuma M
Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
[TBL] [Abstract][Full Text] [Related]
22. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
23. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.
Suzutani T; Saijo M; Nagamine M; Ogasawara M; Azuma M
J Clin Microbiol; 2000 May; 38(5):1839-44. PubMed ID: 10790110
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
Manikowski A; Verri A; Lossani A; Gebhardt BM; Gambino J; Focher F; Spadari S; Wright GE
J Med Chem; 2005 Jun; 48(11):3919-29. PubMed ID: 15916444
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
[TBL] [Abstract][Full Text] [Related]
26. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
27. Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.
Coen N; Duraffour S; Haraguchi K; Balzarini J; van den Oord JJ; Snoeck R; Andrei G
Antimicrob Agents Chemother; 2014 Aug; 58(8):4328-40. PubMed ID: 24820089
[TBL] [Abstract][Full Text] [Related]
28. Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.
De Clercq E; Andrei G; Snoeck R; De Bolle L; Naesens L; Degrève B; Balzarini J; Zhang Y; Schols D; Leyssen P; Ying C; Neyts J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):271-85. PubMed ID: 11563039
[TBL] [Abstract][Full Text] [Related]
29. Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.
Iwayama S; Ono N; Ohmura Y; Suzuki K; Aoki M; Nakazawa H; Oikawa M; Kato T; Okunishi M; Nishiyama Y; Yamanishi K
Antimicrob Agents Chemother; 1998 Jul; 42(7):1666-70. PubMed ID: 9661001
[TBL] [Abstract][Full Text] [Related]
30. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.
Boyd MR; Bacon TH; Sutton D; Cole M
Antimicrob Agents Chemother; 1987 Aug; 31(8):1238-42. PubMed ID: 3631945
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
32. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro.
Gong ZJ; De Meyer S; Clarysse C; Verslype C; Neyts J; De Clercq E; Yap SH
J Viral Hepat; 1999 May; 6(3):229-36. PubMed ID: 10607235
[TBL] [Abstract][Full Text] [Related]
34. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
Balzarini J; Bohman C; Walker RT; de Clercq E
Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
[TBL] [Abstract][Full Text] [Related]
35. Guanosine analogues as anti-herpesvirus agents.
De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1531-41. PubMed ID: 11200257
[TBL] [Abstract][Full Text] [Related]
36. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.
Smee DF; Bray M; Huggins JW
Antivir Chem Chemother; 2001 Nov; 12(6):327-35. PubMed ID: 12018677
[TBL] [Abstract][Full Text] [Related]
37. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Chono K; Katsumata K; Suzuki H; Shiraki K
Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
Abele G; Eriksson B; Harmenberg J; Wahren B
Antimicrob Agents Chemother; 1988 Aug; 32(8):1137-42. PubMed ID: 2847643
[TBL] [Abstract][Full Text] [Related]
39. Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties.
Chuchkov K; Chayrov R; Hinkov A; Todorov D; Shishkova K; Stankova IG
Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):979-990. PubMed ID: 32312162
[TBL] [Abstract][Full Text] [Related]
40. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
